ArticleFrontiers in radiology2026
Dual-phase CT radiomics for acute kidney injury prediction after out-of-hospital cardiac arrest.
Article in Frontiers in radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Acute kidney injury (AKI) is common and prognostically relevant after out-of-hospital cardiac arrest (OHCA), yet early risk prediction at admission remains limited. Objective: To assess whether radiomics features from dual-phase contrast-enhanced CT obtained at admission predict AKI after non-traumatic OHCA. Methods: This retrospective single-center study included consecutive non-traumatic OHCA patients with return of spontaneous circulation undergoing standardized admission dual-phase CT. AKI within 5 days was defined by KDIGO criteria or renal replacement therapy. Bilateral whole-kidney masks were generated using TotalSegmentator, reviewed, and corrected if necessary. Radiomics features were extracted with PyRadiomics within 3DSlicer. Features with poor reproducibility (CCC < 0.75) were excluded. Arterial-venous difference features were computed. Data were split into a training cohort and test cohort. Feature selection used mRMR followed by LASSO regression, yielding seven predictors for training of a logistic regression (LR) model, a support vector machine (SVM), and a k-nearest neighbors (kNN) model. Additionally, a limited clinical variable LR model and a combined model were evaluated. Stability was assessed by Results: Of 383 screened patients, 155 were included, of which 47 (30.3%) developed AKI. In the test cohort, radiomics-LR showed the highest AUC (0.783), with kNN (0.778) and SVM (0.757) performing comparable. The limited clinical model performed poorly (AUC 0.549), and the combined model (AUC 0.779) did not materially improve upon radiomics alone. In the repeated resampling analysis, 29 of 100 repetitions fulfilled the predefined feature-count criterion. Among these repetitions, median test-set AUC was 0.663 (IQR, 0.623-0.699), indicating moderate but variable discriminatory performance and limited feature-selection stability. Most selected predictors were arterial-venous difference features. Conclusions: This exploratory single-center proof-of-concept study suggests that admission dual-phase CT radiomics may contain information relevant to early AKI risk stratification after OHCA, with arterial-venous difference features appearing particularly informative. However, limited stability of feature selection and model performance indicates that these findings should be considered hypothesis-generating and require methodological refinement, comparison with more comprehensive clinical models, and external validation in prospective multicenter cohorts before clinical application can be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.